As the integration of artificial intelligence (AI) into radiology workflows continues to evolve, establishing standardized processes for the evaluation and deployment of AI models is crucial to ensure success. This paper outlines the creation of a Radiology AI Council at a large academic center and subsequent development of framework in the form of a rubric to formalize the evaluation of radiology AI models and onboard them into clinical workflows. The rubric aims to address the challenges faced during the deployment of AI models, such as real-world model performance, workflow implementation, resource allocation, return on investment (ROI), and impact to the broader health system. Using this comprehensive rubric, the council aims to ensure that the process for selecting AI models is both standardized and transparent. This paper outlines the steps taken to establish this rubric, its components, and initial results from evaluation of 13 models over an 8-month period. We emphasize the importance of holistic model evaluation beyond performance metrics, and transparency and objectivity in AI model evaluation with the goal of improving the efficacy and safety of AI models in radiology.

Human epidermal growth factor receptor 2 (HER2) is a crucial determinant of breast cancer prognosis and treatment options. The study aimed to establish an MRI-based habitat model to quantify intratumoral heterogeneity (ITH) and evaluate its potential in predicting HER2 expression status. Data from 340 patients with pathologically confirmed invasive breast cancer were retrospectively analyzed. Two tasks were designed for this study: Task 1 distinguished between HER2-positive and HER2-negative breast cancer. Task 2 distinguished between HER2-low and HER2-zero breast cancer. We developed the ITH, deep learning (DL), and radiomics signatures based on the features extracted from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI). Clinical independent predictors were determined by multivariable logistic regression. Finally, a combined model was constructed by integrating the clinical independent predictors, ITH signature, and DL signature. The area under the receiver operating characteristic curve (AUC) served as the standard for assessing the performance of models. In task 1, the ITH signature performed well in the training set (AUC = 0.855) and the validation set (AUC = 0.842). In task 2, the AUCs of the ITH signature were 0.844 and 0.840, respectively, which still showed good prediction performance. In the validation sets of both tasks, the combined model exhibited the best prediction performance, with AUCs of 0.912 and 0.917 respectively, making it the optimal model. A combined model integrating clinical independent predictors, ITH signature, and DL signature can predict HER2 expression status preoperatively and noninvasively.

The 28th Annual Scientific Sessions of the Society for Cardiovascular Magnetic Resonance (SCMR) took place from January 29 to February 1, 2025, in Washington, D.C. SCMR 2025 brought together a diverse group of 1714 cardiologists, radiologists, scientists, and technologists from more than 80 countries to discuss emerging trends and the latest developments in cardiovascular magnetic resonance (CMR). The conference centered on the theme "Leading the Way to Accessible, Sustainable, and Efficient CMR," highlighting innovations aimed at making CMR more clinically efficient, widely accessible, and environmentally sustainable. The program featured 728 abstracts and case presentations with an acceptance rate of 86% (728/849), including Early Career Award abstracts, oral abstracts, oral cases and rapid-fire sessions, covering a broad range of CMR topics. It also offered engaging invited lectures across eight main parallel tracks and included four plenary sessions, two gold medalists, and one keynote speaker, with a total of 826 faculty participating. Focused sessions on accessibility, efficiency, and sustainability provided a platform for discussing current challenges and exploring future directions, while the newly introduced CMR Innovations Track showcased innovative session formats and fostered greater collaboration between researchers, clinicians, and industry. For the first time, SCMR 2025 also offered the opportunity for attendees to obtain CMR Level 1 Training Verification, integrated into the program. Additionally, expert case reading sessions and hands-on interactive workshops allowed participants to engage with real-world clinical scenarios and deepen their understanding through practical experience. Key highlights included plenary sessions on a variety of important topics, such as expanding boundaries, health equity, women's cardiovascular disease and a patient-clinician testimonial that emphasized the profound value of patient-centered research and collaboration. The scientific sessions covered a wide range of topics, from clinical applications in cardiomyopathies, congenital heart disease, and vascular imaging to women's heart health and environmental sustainability. Technical topics included novel reconstruction, motion correction, quantitative CMR, contrast agents, novel field strengths, and artificial intelligence applications, among many others. This paper summarizes the key themes and discussions from SCMR 2025, highlighting the collaborative efforts that are driving the future of CMR and underscoring the Society's unwavering commitment to research, education, and clinical excellence.

Substantial gaps exist in the neuroprognostication of cardiac arrest patients who remain comatose after the restoration of spontaneous circulation. Most studies focus on predicting survival, a measure confounded by the withdrawal of life-sustaining treatment decisions. Severe cerebral edema (SCE) may serve as an objective proximal imaging-based surrogate of neurologic injury. We retrospectively analyzed data from 288 patients to automate SCE detection with machine learning (ML) and to test the hypothesis that the quantitative values produced by these algorithms (ML_SCE) can improve predictions of neurologic outcomes. Ground-truth SCE (GT_SCE) classification was based on radiology reports. The model attained a cross-validated testing accuracy of 87% [95% CI: 84%, 89%] for detecting SCE. Attention maps explaining SCE classification focused on cisternal regions (p<0.05). Multivariable analyses showed that older age (p<0.001), non-shockable initial cardiac rhythm (p=0.004), and greater ML_SCE values (p<0.001) were significant predictors of poor neurologic outcomes, with GT_SCE (p=0.064) as a non-significant covariate. Our results support the feasibility of automated SCE detection. Future prospective studies with standardized neurologic assessments are needed to substantiate the utility of quantitative ML_SCE values to improve neuroprognostication.

Tumor-infiltrating lymphocytes (TILs) are capable of recognizing tumor antigens, impacting tumor prognosis, predicting the efficacy of neoadjuvant therapies, contributing to the development of new cell-based immunotherapies, studying the tumor immune microenvironment, and identifying novel biomarkers. Traditional methods for evaluating TILs primarily rely on histopathological examination using standard hematoxylin and eosin staining or immunohistochemical staining, with manual cell counting under a microscope. These methods are time-consuming and subject to significant observer variability and error. Recently, artificial intelligence (AI) has rapidly advanced in the field of medical imaging, particularly with deep learning algorithms based on convolutional neural networks. AI has shown promise as a powerful tool for the quantitative evaluation of tumor biomarkers. The advent of AI offers new opportunities for the automated and standardized assessment of TILs. This review provides an overview of the advancements in the application of AI for assessing TILs from multiple perspectives. It specifically focuses on AI-driven approaches for identifying TILs in tumor tissue images, automating TILs quantification, recognizing TILs subpopulations, and analyzing the spatial distribution patterns of TILs. The review aims to elucidate the prognostic value of TILs in various cancers, as well as their predictive capacity for responses to immunotherapy and neoadjuvant therapy. Furthermore, the review explores the integration of AI with other emerging technologies, such as single-cell sequencing, multiplex immunofluorescence, spatial transcriptomics, and multimodal approaches, to enhance the comprehensive study of TILs and further elucidate their clinical utility in tumor treatment and prognosis.

Accurate and efficient segmentation of medical images plays a vital role in clinical tasks, such as diagnostic procedures and planning treatments. Traditional U-shaped encoder-decoder architectures, built on convolutional and transformer-based networks, have shown strong performance in medical image processing. However, the simple skip connections commonly used in these networks face limitations, such as insufficient nonlinear modeling capacity, weak global multiscale context modeling, and limited interpretability. To address these challenges, this study proposes the PDS-UKAN network, an innovative subdivision-based U-KAN architecture, designed to improve segmentation accuracy. The PDS-UKAN incorporates a PKAN module-comprising partial convolutions and Kolmogorov - Arnold network layers-into the encoder bottleneck, enhancing the network's nonlinear modeling and interpretability. Additionally, the proposed Dual-Branch Convolutional Boundary Enhancement Module (DBE) focuses on pixel-level boundary refinement, improving edge detail preservation in shallow skip connections. Meanwhile, the Skip Connection Channel Spatial Attention Module (SCCSA) mechanism is applied in the deeper skip connections to strengthen cross-dimensional interactions between channels and spatial features, mitigating the loss of spatial information due to downsampling. Extensive experiments across multiple medical imaging datasets demonstrate that PDS-UKAN consistently achieves superior performance compared to state-of-the-art (SOTA) methods.

This review explores the use of brain age estimation from MRI scans as a biomarker of brain health. With disorders like Alzheimer's and Parkinson's increasing globally, there is an urgent need for early detection tools that can identify at-risk individuals before cognitive symptoms emerge. Brain age offers a noninvasive, quantitative measure of neurobiological ageing, with applications in early diagnosis, disease monitoring, and personalized medicine. Studies show that individuals with Alzheimer's, mild cognitive impairment (MCI), and Parkinson's have older brain ages than their chronological age. Longitudinal research indicates that brain-predicted age difference (brain-PAD) rises with disease progression and often precedes cognitive decline. Advances in deep learning and multimodal imaging have improved the accuracy and interpretability of brain age predictions. Moreover, socioeconomic disparities and environmental factors significantly affect brain aging, highlighting the need for inclusive models. Brain age estimation is a promising biomarker for identify future risk of neurodegenerative disease, monitoring progression, and helping prognosis. Challenges like implementation of standardization, demographic biases, and interpretability remain. Future research should integrate brain age with biomarkers and multimodal imaging to enhance early diagnosis and intervention strategies.

As the US Food and Drug Administration (FDA)-approved use of artificial intelligence (AI) for medical imaging rises, radiologists are increasingly integrating AI into their clinical practices. In lung cancer screening, diagnostic AI offers a second set of eyes with the potential to detect cancer earlier than human radiologists. Despite AI's promise, a potential problem with its integration is the erosion of patient confidence in clinician expertise when there is a discrepancy between the radiologist's and the AI's interpretation of the imaging findings. We examined how discrepancies between AI-derived recommendations and radiologists' recommendations affect patients' agreement with radiologists' recommendations and satisfaction with their radiologists. We also analyzed how patients' medical maximizing-minimizing preferences moderate these relationships. We conducted a randomized, between-subjects experiment with 1606 US adult participants. Assuming the role of patients, participants imagined undergoing a low-dose computerized tomography scan for lung cancer screening and receiving results and recommendations from (1) a radiologist only, (2) AI and a radiologist in agreement, (3) a radiologist who recommended more testing than AI (ie, radiologist overcalled AI), or (4) a radiologist who recommended less testing than AI (ie, radiologist undercalled AI). Participants rated the radiologist on three criteria: agreement with the radiologist's recommendation, how likely they would be to recommend the radiologist to family and friends, and how good of a provider they perceived the radiologist to be. We measured medical maximizing-minimizing preferences and categorized participants as maximizers (ie, those who seek aggressive intervention), minimizers (ie, those who prefer no or passive intervention), and neutrals (ie, those in the middle). Participants' agreement with the radiologist's recommendation was significantly lower when the radiologist undercalled AI (mean 4.01, SE 0.07, P<.001) than in the other 3 conditions, with no significant differences among them (radiologist overcalled AI [mean 4.63, SE 0.06], agreed with AI [mean 4.55, SE 0.07], or had no AI [mean 4.57, SE 0.06]). Similarly, participants were least likely to recommend (P<.001) and positively rate (P<.001) the radiologist who undercalled AI, with no significant differences among the other conditions. Maximizers agreed with the radiologist who overcalled AI (β=0.82, SE 0.14; P<.001) and disagreed with the radiologist who undercalled AI (β=-0.47, SE 0.14; P=.001). However, whereas minimizers disagreed with the radiologist who overcalled AI (β=-0.43, SE 0.18, P=.02), they did not significantly agree with the radiologist who undercalled AI (β=0.14, SE 0.17, P=.41). Radiologists who recommend less testing than AI may face decreased patient confidence in their expertise, but they may not face this same penalty for giving more aggressive recommendations than AI. Patients' reactions may depend in part on whether their general preferences to maximize or minimize align with the radiologists' recommendations. Future research should test communication strategies for radiologists' disclosure of AI discrepancies to patients.

Heterogeneity is a fundamental characteristic of brain diseases, distinguished by variability not only in brain atrophy but also in the complexity of neural connectivity and brain networks. However, existing data-driven methods fail to provide a comprehensive analysis of brain heterogeneity. Recently, dynamic neural networks (DNNs) have shown significant advantages in capturing sample-wise heterogeneity. Therefore, in this article, we first propose a novel dynamic heterogeneity-aware network (DHANet) to identify critical heterogeneous brain regions, explore heterogeneous connectivity between them, and construct a heterogeneous-aware structural brain network (HGA-SBN) using structural magnetic resonance imaging (sMRI). Specifically, we develop a 3-D dynamic convmixer to extract abundant heterogeneous features from sMRI first. Subsequently, the critical brain atrophy regions are identified by dynamic prototype learning with embedding the hierarchical brain semantic structure. Finally, we employ a joint dynamic edge-correlation (JDE) modeling approach to construct the heterogeneous connectivity between these regions and analyze the HGA-SBN. To evaluate the effectiveness of the DHANet, we conduct elaborate experiments on three public datasets and the method achieves state-of-the-art (SOTA) performance on two classification tasks.

Magnetic Resonance Imaging (MRI) is a widely used medical imaging technique, but its resolution is often limited by acquisition time constraints, potentially compromising diagnostic accuracy. Reference-based Image Super-Resolution (RefSR) has shown promising performance in addressing such challenges by leveraging external high-resolution (HR) reference images to enhance the quality of low-resolution (LR) images. The core objective of RefSR is to accurately establish correspondences between the reference HR image and the LR images. In pursuit of this objective, this paper develops a Self-rectified Texture Supplementation network for RefSR (STS-SR) to enhance fine details in MRI images and support the expanding role of autonomous AI in healthcare. Our network comprises a texture-specified selfrectified feature transfer module and a cross-scale texture complementary network. The feature transfer module employs highfrequency filtering to facilitate the network concentrating on fine details. To better exploit the information from both the reference and LR images, our cross-scale texture complementary module incorporates the All-ViT and Swin Transformer layers to achieve feature aggregation at multiple scales, which enables high-quality image enhancement that is critical for autonomous AI systems in healthcare to make accurate decisions. Extensive experiments are performed across various benchmark datasets. The results validate the effectiveness of our method and demonstrate that the method produces state-of-the-art performance as compared to existing approaches. This advancement enables autonomous AI systems to utilize high-quality MRI images for more accurate diagnostics and reliable predictions.